[Peritoneal Dialysis Network in North-East Italy: Survey About the Peritoneal Catheter Exit-Site Infection Management and Comparison with ISPD Guidelines].

Autor: Previti A; UOS Nefrologia e Dialisi, Ospedale Alto Vicentino, Santorso (VI)., Milan Manani S; UOC Nefrologia e Dialisi, Ospedale Camposampiero e Cittadella (PD)., Cosentini V; UOC Nefrologia e Dialisi, Ospedale Fracastoro, San Bonifacio (VR)., Lo Cicero A; UOC Nefrologia e Dialisi, Ospedale si Sant'Antonio, San Daniele del Friuli (UD)., Guizzo M; UOC Nefrologia e Dialisi, Ospedale Castelfranco Veneto, Castelfranco Veneto (TV)., Apolloni M; UOS Nefrologia e Dialisi, Ospedale Alto Vicentino, Santorso (VI)., Cappellari M; UOC Nefrologia e Dialisi, Ospedale Castelfranco Veneto, Castelfranco Veneto (TV)., Rognini S; UOC Nefrologia e Dialisi, Ospedale Fracastoro, San Bonifacio (VR)., Zuccolo M; UOC Nefrologia e Dialisi, Ospedale si Sant'Antonio, San Daniele del Friuli (UD)., Virzì MG; UOC Nefrologia, Dialisi e Trapianto, Ospedale San Bortolo Vicenza (VI)., Gambaro G; UOC Nefrologia e Dialisi, Azienda Ospedaliera Universitaria Integrata Verona, Verona.

Publikováno v: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia [G Ital Nefrol] 2024 Apr 29; Vol. 41 (2). Date of Electronic Publication: 2024 Apr 29.

How harvest, cleaning and conservation good practices affect the quality of saffron: results of a research conducted in Italy

Autor: Leoni, V., Giupponi, L., Pedrali, D., Zuccolo, M., Borgonovo, G., Bassoli, A., Giorgi, A.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1261::9c0abcfd3ad081c8f900650338056aae
https://hdl.handle.net/2434/935655

Genetic newborn screening and digital technologies: A project protocol based on a dual approach to shorten the rare diseases diagnostic path in Europe.

Autor: Garnier N; Pfizer Inc., Collegeville, Pennsylvania, United States of America., Berghout J; Pfizer Inc., Collegeville, Pennsylvania, United States of America., Zygmunt A; Pfizer Inc., Collegeville, Pennsylvania, United States of America., Singh D; Pfizer Inc., Collegeville, Pennsylvania, United States of America., Huang KA; Pfizer Inc., Collegeville, Pennsylvania, United States of America., Kantz W; Pfizer Inc., Collegeville, Pennsylvania, United States of America., Blankart CR; KPM Center for Public Management and Swiss Institute for Translational and Entrepreneurial Medicine, University of Bern, Bern, Switzerland., Gillner S; KPM Center for Public Management and Swiss Institute for Translational and Entrepreneurial Medicine, University of Bern, Bern, Switzerland., Zhao J; Department of Mathematics and Computer Science, University of Southern Denmark, Odense, Denmark., Roettger R; Department of Mathematics and Computer Science, University of Southern Denmark, Odense, Denmark., Saier C; Department of Neuropediatric and Muscle Disorders, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Kirschner J; Department of Neuropediatric and Muscle Disorders, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Schenk J; Takeda Pharmaceuticals International AG, Opfikon, Switzerland., Atkins L; Takeda Pharmaceuticals International AG, Opfikon, Switzerland., Ryan N; Takeda Pharmaceuticals International AG, Opfikon, Switzerland., Zarakowska K; Takeda Pharmaceuticals International AG, Opfikon, Switzerland., Zschüntzsch J; Department of Neurology, University Medical Center Goettingen, Göttingen, Germany., Zuccolo M; F. Hoffmann La-Roche, Basel, Switzerland., Müllenborn M; Novo Nordisk Health Care AG, Switzerland &Novo Nordisk A/S, Kloten, Denmark., Man YS; Novo Nordisk Health Care AG, Switzerland &Novo Nordisk A/S, Kloten, Denmark., Goodman L; University College Dublin, National University of Ireland, Dublin, Ireland., Trad M; Lysogene, Neuilly-sur-Seine, France., Chalandon AS; Sanofi, Diegem, Belgium., Sansen S; Sanofi, Diegem, Belgium., Martinez-Fresno M; Illumina, Cambridge, United Kingdom., Badger S; Illumina, Cambridge, United Kingdom., Walther van Olden R; Novartis Gene Therapies Switzerland GmbH, Risch-Rotkreuz, Switzerland., Rothmann R; Research Institute AG & Co KG, Digital Human Rights Center, Wien, Austria., Lehner P; Research Institute AG & Co KG, Digital Human Rights Center, Wien, Austria., Tschohl C; Research Institute AG & Co KG, Digital Human Rights Center, Wien, Austria., Baillon L; PTC Therapeutics Switzerland GmbH, Steinhausen, Switzerland., Gumus G; EURORDIS, Paris, France., Gross E; EURORDIS, Paris, France., Stefanov R; Department of Social Medicine and Public Health, Faculty of Public Health, Medical University of Plovdiv, Plovdiv, Bulgaria.; Bulgarian Association for Promotion of Education and Science, Institute for Rare Disease, Plovdiv, Bulgaria., Iskrov G; Department of Social Medicine and Public Health, Faculty of Public Health, Medical University of Plovdiv, Plovdiv, Bulgaria.; Bulgarian Association for Promotion of Education and Science, Institute for Rare Disease, Plovdiv, Bulgaria., Raycheva R; Department of Social Medicine and Public Health, Faculty of Public Health, Medical University of Plovdiv, Plovdiv, Bulgaria.; Bulgarian Association for Promotion of Education and Science, Institute for Rare Disease, Plovdiv, Bulgaria., Kostadinov K; Department of Social Medicine and Public Health, Faculty of Public Health, Medical University of Plovdiv, Plovdiv, Bulgaria.; Bulgarian Association for Promotion of Education and Science, Institute for Rare Disease, Plovdiv, Bulgaria., Mitova E; Bulgarian Association for Promotion of Education and Science, Institute for Rare Disease, Plovdiv, Bulgaria., Einhorn M; Genoox, Tel Aviv, Israel., Einhorn Y; Genoox, Tel Aviv, Israel., Schepers J; Berlin Institute of Health (at) Charité - Universitätsmedizin Berlin, Berlin, Germany., Hübner M; Berlin Institute of Health (at) Charité - Universitätsmedizin Berlin, Berlin, Germany., Alves F; Translational Molecular Imaging, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.; Clinic of Hematology and Medical Oncology, University Medical Center, Göttingen, Germany.; Institute for Diagnostic and Interventional Radiology, University Medical Center, Göttingen, Germany., Iskandar R; Swiss Institute for Translational and Entrepreneurial Medicine (sitem-insel), Bern, Switzerland., Mayer R; SBA Research gGmbH, Wien, Austria., Renieri A; Medical Genetics, University of Siena, Siena, Italy., Piperkova A; Bulgarian Association for Personalized Medicine, Sofia, Bulgaria., Gut I; Centro Nacional de Analisis Genomico, CNAG, Barcelona, Spain., Beltran S; Centro Nacional de Analisis Genomico, CNAG, Barcelona, Spain., Matthiesen ME; FindZebra APS, Copenhagen, Denmark., Poetz M; Department of Strategy and Innovation, Copenhagen Business School, Copenhagen, Denmark., Hansson M; Uppsala University, Uppsala, Sweden., Trollmann R; University of Erlangen, Erlangen, Germany., Agolini E; Bambino Gesu' Children Hospital, IRCCS, Rome, Italy., Ottombrino S; Bambino Gesu' Children Hospital, IRCCS, Rome, Italy., Novelli A; Bambino Gesu' Children Hospital, IRCCS, Rome, Italy., Bertini E; Bambino Gesu' Children Hospital, IRCCS, Rome, Italy., Selvatici R; Medical Genetics, Department of Medical Sciences, University of Ferrara, Ferrara, Italy., Farnè M; Medical Genetics, Department of Medical Sciences, University of Ferrara, Ferrara, Italy., Fortunato F; Medical Genetics, Department of Medical Sciences, University of Ferrara, Ferrara, Italy., Ferlini A; Medical Genetics, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.

Publikováno v: PloS one [PLoS One] 2023 Nov 22; Vol. 18 (11), pp. e0293503. Date of Electronic Publication: 2023 Nov 22 (Print Publication: 2023).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Caffeic acid phenethyl ester targets ubiquitin-specific protease 8 and synergizes with cisplatin in endometrioid ovarian carcinoma cells.

Autor: Colombo D; Department of Medical Biotechnology and Translational Medicine, University of Milano, Via Saldini 50, 20133 Milan, Italy., Gatti L; Neurobiology Laboratory, Neurology IX, UCV, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy., Sjöstrand L; Department of Biomedical and Clinical Sciences, Linköping University, Sweden., Carenini N; Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 31, 20133 Milan, Italy., Costantino M; Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 31, 20133 Milan, Italy., Corna E; Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 31, 20133 Milan, Italy., Arrighetti N; Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 31, 20133 Milan, Italy., Zuccolo M; Department of Medical Biotechnology and Translational Medicine, University of Milano, Via Saldini 50, 20133 Milan, Italy., De Cesare M; Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 31, 20133 Milan, Italy., Linder S; Department of Biomedical and Clinical Sciences, Linköping University, Sweden; Division of Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., D'Arcy P; Department of Biomedical and Clinical Sciences, Linköping University, Sweden., Perego P; Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 31, 20133 Milan, Italy. Electronic address: paola.perego@istitutotumori.mi.it.

Publikováno v: Biochemical pharmacology [Biochem Pharmacol] 2022 Mar; Vol. 197, pp. 114900. Date of Electronic Publication: 2022 Jan 05.